Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADX10059 for dental anxiety during dental treatment
2006-003912-23Phase 2Completed
- Sponsor
- Addex Therapeutics Ltd
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Dental anxiety comparing ADX10059 arm with Placebo arm (2 arms). Primary endpoint: VAS-Anxiety score at 60 minutes post dose. Started Sep 2006; status: completed.
02
Drugs
raseglurant
03
Conditions
Dental anxiety
Beyond the preview
Go deeper on 2006-003912-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003912-23.